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From the 
President 
At its April 
meeting, the Medical Executive 
Committee voted on several important 
issues. The committee endorsed the 
Board of Trustees' reports on 
Education and Chairpersons. These 
two documents express the direction 
and intent the Board envisions for our 
hospital. As previously noted, these 
documents have been available in the 
Medical Staff Office; however, as the 
contents of these documents are 
important for our active :¥edical Staff, 
copies will be provided at the next 
General Medical Staff meeting. 
The Medical Executive Committee also 
voted to remove itself from the process 
of reviewing and making 
recommendations concerning requests 
for Medical Staff Development slots. 
We struggled to this conclusion after 
considering the tangled deliberations of 
the Medical Executive Committee 
when reviewing slots/slot applications. 
The department chairperson would 
solicit input from his division and 
make his recommendations (as well as 
the division recommendations, if 
contrary) to a group consisting of the 
11 departmental chairpersons, the 
hospital CEO, COO, Chief of Clinical 
Services, hospital counsel, Vice 
President for Medical Staff Services, 
and members of TROIKA. A report 
from this group would be sent to the 
Medical Executive Committee for 
informational purposes and sent 
directly to the Quality 
Assurance/Medical Allied Health Staff 
Development Committee of the Board 
which would then submit its 
recommendations to the Board of 
Trustees. 
A modification of the so called two 
year rule was also passed. 
Immediately upon receipt of 
notification from a private practice 
group that an individual has been 
involuntarily terminated from the 
group, or when an individual is no 
longer employed under a contract with 
the hospital, that individual would lose 
medical staff privileges and 
membership. These individuals would, 
however, be permitted to request a slot 
within 60 days of such notification, 
requiring immediate consideration by 
the new hospital group mentioned 
above, the Quality Assurance/Medical 
Allied Staff Development Committee of 
the Board, and the Board of Trustees at 
their next scheduled meeting. 
Voluntary termination from either 
private practice groups or hospital 
contracts will be reviewed only during 
the normal Semiannual Needs Survey 
cycle. 
Continued on Page 2 
Continued from Page 1 
The Medical Staff Development Plan 
has been a source of much 
consternation in its individual 
application. The general principles of 
the plan, however, remain an important 
document which the Medical Staff, 
through the Medical Executive 
Committee, must maintain input and 
provide insight. In that regard, we 
will be reviewing those principles in a 
upcoming meeting of the Medical 
Executive Committee. 
Finally, a quick update on the 
Managed Care initiative. The first 
draft of the Business Plan has been 
completed, and TROIKA reviewed it 
with Dan Grauman of the Raleigh 
Group. It is being distributed to our 
Managed care Committee for further 
discussion and revision. We have been 
very active in formulating our plan at a 
rapid pace. The issue of capitation/ 
gatekeeper concept also needs to be 
faced if we are to be perched 
competitively in the managed care 
arena. A group of primary care 
practitioners and Tom Hansen, Senior 




President, Medical Staff 
At-Large Members Needed for Medical Executive 
Committee 
The Medical Staff Nominations 
Committee is soliciting nominations for 
four at-large seats, each for a three-
year term beginning July 1, 1993, on 
the Medical Executive Committee. 
Nominations should be submitted in 
writing to John E. Castaldo, M.D., 
Chairman of the Nominating 
Committee, via the Medical Staff 
Services Office, Cedar Crest & 1-78, 
or verbally to Joseph A. Candio, 
M.D., Medical Staff President, John 
Jaffe, M.D., Past President, Medical 
Staff, or John W. Hart, Vice President. 
All nominations must be submitted 
prior to June 1, 1993. 
If you have any questions regarding 
this issue, please contact Dr. Castaldo 
or Mr. Hart at 402-8968. 
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Physician Parking Changes- Cedar Crest & 1-78 
Effective Monday, May 17, 1993, 
physician parking was expanded and 
temporarily relocated to a new lot 
which provides physicians with over 30 
new spaces (please refer to the map on 
page 16). The new lot is gated and 
card accessible as it has been in the 
past. 
Additionally, the relocation and 
expansion of physician parking 
provides an increased number of 
patient parking spaces in response to 
the growing demand from patients of 
the 1210 Medical Office Building. 
The relocation of physician parking is 
timely because of an upcoming 
construction project that will displace 
many spaces in the current physician 
lot. In June, temporary trenching will 
occur so that pipework can be laid to 
connect the hospital boiler system to 
the John and Dorothy Morgan Cancer 
Center. The trenching will pass 
through the former physician lot 
(please refer to the map). 
After the trench work is completed, the 
parking spaces formerly occupied by 
physicians will be dedicated to 
accommodate the additional patient 
parking needed. It is anticipated that 
physician parking will return to the 
original lot upon completion of the 
Dorothy and John Morgan Cancer 
Center. 
Thank you for your continued 
cooperation since the early stages of 
the construction for the John and 
Dorothy Morgan Cancer Center. In 
particular, a special thank you to the 
tenants of 1210, 1220 and 1230 S. 
Cedar Crest Blvd., for their patience 
with regards to parking and other 
issues that have affected them during 
this time. 
If you have any questions regarding 
this issue, please contact either John 
W. Hart, Vice President, or Joseph A. 
Candio, M.D., Medical Staff 
President, at 402-8968. 
Physician Hotline for Patient Census 
Effective May 8, 




402-4508 will be 
manned and accepting calls from 
physicians who wish to inquire as to 
the daily census of their patients at 
both sites of Lehigh Valley Hospital. 
Information Services is pleased to 
support this request, and will be 
automating the process as soon as 
possible, offering fax service and 
computer notification directly off the 
computer mainframe. Unfortunately, 
availability of these services is not 
anticipated for at least 60 to 90 days, 
but it is hoped that this telephone 
number and staffing will be helpful. 
Pagel 
Laboratory 
Update News from the Microbiology Division 
a Sporadically, the Microbiology 
Division of Health Network 
Laboratories receives urine specimens 
obtained by "suprapubic" collection. 
When these are received, the 
laboratorian must call the nursing unit 
in order to establish whether the 
specimen was collected by suprapubic 
"aspiration" or "catheterization" since 
they are processed differently. In 
contrast to catheterized specimens, 
aspirates are cultured as closed body 
site fluids and all organisms isolated 
are identified. It has been found, 
however, that most, if not all, 
specimens received are, in fact, 
collected by "suprapubic 
catheterization. " 
In order to assure that urines collected 
by aspiration are processed correctly, 
please mark the chart under physician 
orders "suprapubic aspirate for C&S" 
and submit the specimen in a sterile 
Port-A-Cui transport vial. All other 
specimens marked as "suprapubic" on 
the Microbiology Request Form will be 
processed as a catheter collected 
specimen. 
a Based on new National Committee 
of Clinical Laboratory Standards 
(NCCLS M110-S4) recommendations, 
the "moderately susceptible" category 
for ampicillin and penicillin 
susceptibility testing of Enterococcus 
spp. has been deleted. There are now 
two categories that may be reported, 
i.e., "susceptible" and "resistant." The 
"susceptible" category for penicillin or 
ampicillin implies the need for high 
dose therapy for serious enterococcal 
infections. According to the NCCLS 
guidelines, enterococcal endocarditis 
requires combined therapy with high 
dose penicillin or high dose ampicillin, 
or vancomycin, or teicoplanin plus 
gentamicin or streptomycin for 
bactericidal action. Detection of 
ampicillin or penicillin resistance for 
enterococci due to B-lactamase 
production is not possible by the 
routine disk diffusion or dilution MIC 
methods. Therefore, blood and CSF 
isolates will be tested using a method 
that will detect B-lactamase. We will 
continue to screen for aminoglycoside 
susceptibility as a means of identifying 
isolates that will respond 
synergistically to ampicillin or 
penicillin and an aminoglycoside. 
a The Microbiology Division of 
Health Network Laboratories has 
implemented the following policy basa. 
on recent reports in the literature 
related to inappropriate testing for 
diarrheal disease. 
o The laboratory performs a 
screen for direct Giardia 
antigen testing. Since the 
greater percentage of specimens 
are positive for this parasite, the 
lab recommends ordering a 
Giardia antigen screen rather 
than a comprehensive Ova & 
Parasite examination. Orders 
must specify Giardia antigen 
screen or Comprehensive Ova 
& Parasite exam. Specimens 
will be stored in the laboratory 
for five days following the final 
Giardia screen report, before 
discarding them. 
Continued on Page 5 
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The lab may be contacted 
within this five-day period at 
402-8190 if further parasite 
evaluation is required. 
o Only one stool specimen for 
ova and parasite should be 
submitted in order to document 
a parasitic infection. The 
previous recommendation 
requiring three samples was 
based on an old epidemiological 
study with asymptomatic 
patients. An exception to this 
recommendation relates to 
intermittent shedding associated 
with Giardia Iamblia. If the 
Giardia antigen screen is 
negative, but you still suspect 
this parasite, submit a second 
specimen at least three days 
after the first specimen for a 
repeat Giardia antigen screen. 
Scheduling of Ultrasounds 
a Recently' the Department of 
Radiology/Diagnostic Medical Imaging 
discontinued obstetrical ultrasound 
services. As a result, the previous 
backlog of other ultrasound requests, 
as long as several weeks at 17th & 
Chew, has been eliminated. 
Routine outpatient ultrasound studies 
can now be performed in one or two 
days of request at 17th & Chew. In 
addition, prostate ultrasound· and 
biopsy protocols are now uniform at 
both sites. These procedures can be 
scheduled with little or no delay at 
17th & Chew. To schedule an ultra-
o Stool specimens for Culture 
and Ova and Parasites will not 
routinely be processed when 
collected from inpatients who 
have been hospitaliml for more 
than three days. However, if 
the epidemiology or clinical 
findings, e.g., 
immunocompromised host, 
warrant processing of a 
specimen submitted more than 
three days post-admission, 
physicians may contact Georgia 
Colasante, Microbiology 
Supervisor, at 402-8190, or 




sound at 17th & Chew, call 402-2450; 
at Cedar Crest & 1-78, call 402-8080. 
If you have any questions regarding 
this issue, please contact Thomas R. 
Fitzsimons, M.D., radiologist, at 
402-2214. 
a Obstetrical ultrasounds are now 
handled through the Perinatal 
Diagnosis Testing Center located in the 
Center for Women's Medicine. 
Obstetrical ultrasounds may be 
scheduled by called 402-9595 (until 
May 24). After. May 24, the number 




a The Health Sciences Library at 
Cedar Crest & I-78 is seeking 
donations of the following journals: 
Mayo Clink Ptvceldings - Volume 67 
115 (May), 16 (June), #7 (July), and #8 
(August), 1992. 
Joul'lllll of Nru:lear Ml4idae -
Volume 32 #11 (November), #12 
(December), 1991. 
Bmergeney Medkine - Volume 23 
#14, #15, #18, #20, 1991. 
Emergency Medkine- Volume 24 #1, 
1992. 
a The following journals are now 
available in the Computer Laboratory 
section of the library: 
Conaputen tllld Biomediclll Eductltion 
Conaputen cl Ml4idae 
M.D. Conaputing 
Phyricilm1 tllld Conaputen 
Celebration of Life -
Lehigh Valley Hospital is sponsoring a 
Celebration of Ufe to heighten 
awareness of the importance of 
mammography and to increase patient 
awareness of Lehigh Valley Hospital's 
women's health services. 
The campaign kicked off on May 1 
with 20,000 seed boxes mailed to 
women ages 40 to 64 in Lehigh Valley 
Hospital's primary service area. The 
boxes contain a packet of flower seeds, 
a booklet on mammography and breast 
self examination, and a $10.00 
discount off mammography services at 
Lehigh Valley Hospital. 
a New acquisitions to the Health 
Sciences Library at 17th & Chew 
include: 
Gabbe. Ob*lrlcs: Nol'llllll tllld 
Ptvblem Preg111111CU1. 2nd ed., 
Churchill Livingstone, 1991. 
Guyton. HUIIUIIJ PhyliolDgy tllld 
Mecluudsm of Dis~~Ue. 5th ed., W.B. 
Saunders, 1992. 
a Remote Access to Medline is still 
going strong. For current information 
regarding additional databases 
available, contact Sherry Giardiniere at 
402-8406. 
Office displays with seed packets are 
also being distributed to participating 
physician offices specializing in 
obstetrics and gynecology, internal 
medicine, family practice, and general 
surgery. 
In July, Comprehensive Breast Services 
brochures will be sent to all 
participating physician offices to 
replace the seed packets in the waiting 
room displays. 
For more information or to participate, 





Neurophysiology Lab Extends Hours 
The Lehigh Valley Hospital 
Neurophysiology Laboratory is 
dedicated to meeting the growing needs 
of the community. Therefore, in order 
to provide more convenient service for 
your patients, beginning May 10, the 
hours for outpatient services will be 
extended. 
New hours for the Neurophysiology 
Laboratory at Cedar Crest & 1-78 are 
Monday, Tuesday, Wednesday, and 
Friday from 7 a.m. to 5:30p.m.; 
Thursday from 7 a.m. to 8 p.m.; and 
Saturday from 8 a.m. to 2 p.m. 
The hours for the laboratory at 17th & 
Chew will remain the same - 8:30 
a.m. to 4:30p.m., Monday through 
Friday. 
Services currently available for 
pediatric and adult patients include: 
o Electroencephalography (BEG) 
-Routine 
- Sleep/ Awake - with Anterior 
Temporal Leads 
News from Home Care 
Richard Steigerwalt has returned to the 
Lehigh Valley Hospital family as 
Physical Therapy Manager of Lehigh 
Valley Home Care. Many of you may 
remember Dick, who has 32 years 
experience in physical therapy. Prior 
to the hospital merger, Dick was Chief 
of Physical Therapy from 1962 to 1969 . 
at Allentown Hospital, Director of 
o 24° Ambulatory Monitoring (BEG) 
o Long Term Video Monitoring (BEG) 
o Brainstem Auditory Evoked 
Potentials 
o Visual Evoked Potentials 
o Somatosensory Evoked Potentials 
- Upper & Lower Extremities, OR 
Monitoring 
o Visual Fields Testing 
o Multiple Sleep Latency Testing 
(MSLT) 
o EMGINC Testing 
o Botulinum Toxin Injections (Botox) 
- for treatment of Dystonia 
(Torticollis, Blepharospasm, 
Hemi-facial Spasm, and focal 
limb Dystonia) 
o Autonomic Testing 
For additional information or 
scheduling, please call the 
Neurophysiology Laboratory at 402-
8860 (Cedar Crest & 1-78) or 402-2297 
(17th & Chew). 
Physical Therapy from 1970 to 1974 at 
Allentown Hospital, and Director of 
Physical Therapy at Lehigh Valley 
Hospital Center from 1974 to 1984. 
During the last nine years, Dick has 
served as Director of Physical Therapy 




Frequently, the Department of Legal 
Services/Risk Management receives 
telephone requests for information 
from the Medical Staff related to legal 
issues, ethical concerns, risk 
management, and insurance questions. 
In response to these requests, this 
column will appear in Medical Stqff 
Progress Notes every other month. 
Your input and questions are welcome. 
Insurance policy questions are a 
frequent area of concern. Good advice 
includes re-reading your policy at least 
once a year to make sure it covers you 
for what you actually do. If you are 
changing insurance companies, you 
may want to call the State Insurance 
Department for information about the 
solvency of the company. A new 
company offering lower rates to secure 
your business may be placing 
themselves at a high risk (and you 
also, if the company folds just when 
you need them!). You may also want 
to check the rating assigned by Best. 
In assigning letter grades to each 
company, consideration is given to 
assets, management, loss reserves, and 
profitability. Obtaining a copy of the 
company's financial statement is also 
helpful. Check to see if it is certified 
by one of the national accounting 
firms. Ask your own accountant to 
look at it to see if the carrier's reserves 
seem adequate. Find out if the 
company is backed by the State 
Guaranty Fund, which pays claims 
against insurers if the company goes 
bankrupt. Check with your colleagues 
to find out what kind of service you 
will receive after you are sued. You 
should determine what your rights are 
in choosing counsel if you are sued. 
Since the limits of insurance coverage 
are actually state mandated in 
Pennsylvania, you generally do not 
have to be concerned about deciding 
how much insurance you should carry. 
The primary limits will be provided as 
required by state law, and of course, 
every health care provider in 
Pennsylvania also has a million dollar 
secondary layer provided by the CAT 
Fund. (The Medical CAT Fund is not 
to be confused with the Automobile 
CAT Fund.) 
Most malpractice policies today are 
claims-made, this pays only if the 
incident occurs and the claim is 
brought within the policy period. If 
you leave a claims-made policy, you 
may need to buy a tail, which can cost 
as much as six times the cost of your 
last years premium. It is vitally 
important that you notify the carrier as 
soon as you become aware of a 
potential claim. Many policies do not 
cover libel and slander, intentional, 
criminal, grossly negligent acts, as 
well as sexual misconduct. 
If your carrier doubts that a particular 
claim should be covered, they will 
send you a "Reservation of Rights" 
letter. Your defense will continue, but 
the carrier may refuse to pay the 
ultimate judgment. If you receive such 
a letter, you should inform your 







In an effort to provide you with 
nutrition information which may 
benefit your patients, this column will 
appear in the newsletter regularly. 
The Prudent Diet 
by Barbara CarlsonM.S., lt.D. 
How many inpatients are educated on 
the prudent, low fat, low cholesterol 
diet every month at Lehigh Valley 
Hospital? The answer: over 200 
individuals receive education on this 
diet prior to discharge. 
Looking toward the future, however, 
clinical dietitians, along with all other 
hospital departments, anticipate shorter 
patient stays. Shortened patient stays 
will require more rapid education and 
intervention. The short time 
constraints will require diet education 
to be accomplished when patients are 
still acutely ill and unable to fully 
comprehend their diet. 
However, the clinical dietitians have a 
strong desire to provide quality 
education with useful, workable 
guidelines and goals which will give 
patients the information needed to 
modify their diet after they leave 
Lehigh Valley Hospital. 
The Clinical.Nutrition Department 
decided to try a new approach toward 
cardiac diet education. Beginning 
April 12, an early evening class for 
cardiac patients and their families was 
initiated. The class is offered from 
6:30 to 7:30p.m., two Monday 
evenings each month. 
The one-hour class is available and 
appropriate for patients prior to 
admission, after discharge, or during 
their hospital stay. Family members 
and caretakers are welcome and 
encouraged to attend. 
Topics covered in the class include: 
o selecting a diet with 20% or 
less of the calories from fat 
(under 7% saturated) 
o limiting cholesterol to 175mg 
per day or less 
o increasing dietary fiber and 
decreasing simple sugars 
o the relationship of blood lipids 
(cholesterol and triglycerides) to 
coronary artery disease and 
current knowledge about diet 
control 
o interpreting food ·labels 
correctly 
o dining out and special occasions 
This class is free of charge to any 
patient referred by a member of Lehigh 
Valley Hospital's Medical Staff. A 
prescription slip should be sent with 
the patients you refer. Notification 
will be sent to your office after your 
patient attends the class. 
A brochure describing the class, dates 
offered, and reservation information is 
available through Clinical Nutrition 
Services. For copies of the brochure 
or if you have any questions regarding 
this new class, call the Clinical 
Dietitians's Office at 402-8313. 
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Short Stay Unit Changes Name 
Effective May 8, the Short Stay Unit 
changed its name to 3C with the 
implementation of PHAMIS I..astWord. 
All signs will be changed to reflect 3C. 
Patient location in the LastWord 
system will be 3C plus the room 
number, i.e., 3C11A. 
News from Research 
Calls for abstracts have been issued by 
the American College of 
Gastroenterology for the 58th Annual 
Scientific Meeting to be held in New 
York on October 4, 1993. Submission 
due date is May 31. 
Letters of Appreciation 
If you have any questions, please 
contact Julia Clelland, Director, Patient 
care Services, 3C, at 402-8228. 
For instructions, forms, and further 
information, contact Kathleen Moser in 





Jeffrey L. Gevirtz, M.D., urologist, 
was recently informed that he 
successfully completed all the 
requirements for certification and is 
now certified as a Diplomate of the 
American Board of Urology. 
Lester Rosen, M.D., colon-rectal 
surgeon, has been appointed to a two-
year term as an Associate Examiner by 
the American Board of Colon and 
Rectal Surgery. As an Associate 
Examiner, he will be involved in all 
aspects of the examination process for 
board certification in colon and rectal 
surgery, including preparation of test 
items for the written examination and 
participation in the oral examination. 
Dolores M. Sarno-Kristofits, Ph.D., 
psychologist, successfully completed 
her doctorate at Temple University. 
The title of her dissertation is 
Ericksoulan Psychosocial Stqes of 
Development and its Relatio:nsbip to 
Post-Traumatic Stress Syndrome. 
Edward A. Tomkin, D.O., 
otolaryngologist, was recently certified 
in Otorhinolaryngology and Facial 
Plastic Surgery by the American 
Osteopathic Board of Ophthalmology & 
Otorhinolaryngology. 
Publications, Papers and Presentations 
Glen L. Ollver, M.D., ophthalmol-
ogist, recently attended the fourth 
meeting of the Schepens International 
Society jointly organized with the 
Chinese University of Hong Kong in 
Hong Kong. He presented a 27-year 
follow-up of the Oliver-McFarlene 
Syndrome (Congenital Trichomegaly 
with Associated Dwarfism, Pigmentary 
Retinal Degeneration, Mental 
Retardation and Cerebellar 
Degeneration). Nine other cases have 
now been reported in the literature. 
Evidence of axonal peripheral 
neuropathy and cerebellar degeneration 
was found in this patient and its 
development should be anticipated 
when the syndrome is recognized in 
younger people. 
Dr. Oliver also co-authored an article, 
Necrotic Orbital Melanoma Arising 
De Novo, which was published in the 
February, 1993 issue of the British 
Journal of OphtluJlmology. 
Robert B. Kevitch, M.D., plastic and 
reconstructive surgeon, participated in 
a panel discussion as part of a program 
entitled Breast Health in the 90's. 
The program took pl8ce in East 
Stroudsburg and was sponsored by the 
American Cancer Society. 
lndm T. Khubchandani, M.D., 
colon-rectal surgeon, was invited to 
participate in a Round Table on 
Compllc:atious in DJaestive Stoma at 
the First World Ostomy Congress for 
Health Professionals in Madrid, Spain, 
on Apri113 to 16. The meeting was 
organized by the Spanish Ostomy 
Association with International 
Cooperation from World Health 
Organization (WHO) and International 
Ostomy Association (lOA). 
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Upcoming Seminars, Conferences, and Meetings 
Medical Grand Rounds 
Rheumatic Fever in the 90's and Post 
Streptococcal Diseases will be 
presented by Donald D. Goldsmith, 
M.D., Professor of Pediatrics, Temple 
University School of Medicine, and 
Director of Rheumatology, St. 
Christopher's Hospital, Philadelphia, 
on Tuesday, May 18. 
Non-Steroidals in the Elderly will be 
presented by John DiGreggorio, M.D., 
Professor of Pharmacology and 
Medicine, Hahnemann University, 
Philadelphia, on Tuesday, May 25. 
Medical Grand Rounds are held on 
Tuesday of each week beginning at 
noon in the Auditorium of Lehigh 
Valley Hospital, Cedar Crest & 1-78. 
For more information, contact the 
Department of Medicine at 402-8200. 
Department of Pediatrics 
Members of the faculty of St. 
Christopher's Hospital for Children, 
Philadelphia, will participate in the 
Pediatric Symposium on Thursday, 
May 20, from 1 to S p.m., in the 
Auditorium of Lehigh Valley Hospital, 
Cedar Crest & 1-78. Topics and 
speakers include What's New in the 
DiGeoqe Syndrome to be presented 
by Angelo DiGeorge, M.D.; Chrome 
Pain in ChUdren and Adolescents by 
David Smith, M.D.; and Kidney 
Transplants in ChUdren: ll Years' 
Experience by H. Jorge Baluarte, 
M.D. Waldo Nelson, M.D., will 
serve as Panel Moderator. 
Update on Urioary Tract Infectious 
will be presented by Charles Reed, 
M.D., Chief, Section of General 
Pediatrics, St. Christopher's Hospital 
for Children, on Friday, June 4, at 
noon. 
Case ·Presentations in Pediatric 
Emer&enc:ies will be presented by 
Douglas Baker, M.D., Division of 
Emergency Medicine, Children's 
Hospital of Philadelphia, on Friday, 
June 18, at noon. 
All conferences, except the Pediatric 
Symposium, will be held in the 
Auditorium at 17th & Chew. 
For more information, contact Beverly 
Humphrey in the Department of 
Pediatrics at 402-2410. 
Psychiatric Grand 
Rounds 
Review of the Catatonic Syndrome 
will be presented by Gregory 
Fricchione, M.D., Department of 
Psychiatry, Health Sciences Center, 
State University of New·York at Stony 
Brook, on Thursday, May 20, at noon, 
in the Auditorium of Lehigh Valley 
Hospital, 17th & Chew. 
As lunch will be provided, 
preregistration is requested. For more 
information or to register, call Lisa in 




• For Sale or Leae - Springhouse 
ProfealoMI c .. t •• 1575 Pond Road. Ideal 
for phyllc:IM's office. Approxlmetely 2,500 
sq. ft. Wll finish spece to specifications. 
• For Sale or Leae - Medlcal-profealoMI 
office building on South C... Crest 
Boulftn, just mhlt• tram Ceder Crest • 1-
78 8lld 17th. Chew. 3,580 tOUIIsq. ft. 
Ample pMdne. ucurltylftre alarms Installed. 
Ideal for .,...,.._. group. 
• For Sale - Office building et Northeat 
c:onw of 19th 8lld T..,... Streets In 
Alentown. UPI* level- 2,400+ sq. ft., large 
welting room, two a.ge COR8Uitatlon rooms. 
five uem rooms. etc. Low• level - 2,300 + 
sq. ft. Perking lot for 18 '*-· 
• For Leae - Medlcel office space located In 
Puchtree Office Plue In Whltehell. One suite 
with 1 ,500 sq. ft. (Wiflnlthed - allowance 
avellableJ, and one 1 ,000 sq. ft. finished suite. 
• For LeMa- Medlcel-prof•slonel office 
spece located on Route 222 In W•cosvlle. 
Two 1 ,000 sq. ft. offices available or combine 
to form l•ger suite. 
WHO'S NEW 
The Who's New section of Medical 
Skiff Progress Notes contains an 
update of new appointments, address 
changes, newly approved privileges, 
etc. 
Please remember that each department 
or unit is responsible for updating its 
directory, rolodexes, and approved 
privilege rosters. 
Medical Staff 
Change of Address 
Domenic M. Falco, DO 
Emaus Avenue Family Practice 
1101 W. Emaus Avenue 
Allentown, PA 18103 
• For Leae - Medical office space located In 
Southeest Allentown ....- Mounulnvlle 
Shopping Cent•. 
• For Leese - Slota .. currently ..,....,._ for 
the Brown Beg suite et Kutztown Profeulonal 
C..t•. 
• For Leae - SMre l•ge medical office n .. 
Ceder Crest • 1-78. Fuly fumllhed llld 
staffed. Multiple lne phone ~em. 
Computerized .... ..,....,.., 
• For Leae - Spec:llfty prectlce tlme-stwre 
spece .., ....... In • comprehensive heelth -=-• 
fedlty ........ Profenlonel en.. 4019 
Wymewood Drive. Leurya Stetlon. Helf- or 
ful.dey llotlllmrnedletely .., ......... 
• For L ... e - Shere spece In MOB 1 on the 
campus of Lehigh Veley Hospital. Ceder Crest 
• 1-78. Approxlmetely 1 ,000 sq. ft. Three 
exam rooms. 
For more lnformetlon or for •~ce In 
finding epproprlllte office spece to meet your 
needs, contect Joe Pile, POPS Rep, et 
402-9856. 
Daniel M. Rappaport, MD 
Mishkin, Rappaport, Shore 
3321 Chestnut Street 
Whitehall, PA 18052 
(215) 262-7123 
(Effective June 1, 1993) 
Jo-Anne A. Steward, MD 
Fogelsville Medical Associates 
7671 Schantz Road 
P.O. Box 952 
Fogelsville, PA 18051-0952 
(215) 395-3400 
Lehigh Valley Medical Associates 
(James T. McNelis, DO, Michael R. Goldner, 
DO, and John M. Kauffman, Jr., DO) 
1255 S. Cedar Crest Blvd. 
Suite 2200 
Allentown, PA 18103 
(Effective June 11, 1993) 
Continued on Page 14 
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Appointment of Medical 
Director - Ambulatory 
Pediatrics 
Cbarles F. Smith, MD 
Additional Privileges 
1bomas D. Meade, MD 
Department of Surgery 
Division of Orthopedic Surgery 
Section of Orthopedic Trauma 
Endoscopic Carpal Tunnel Release 
Privileges 
Daniel M. SUverbeq, MD 
Department of Surgery 
Division of Urology 
YAG and C~ Laser Privileges 
F. Geoffrey Toonder, MD 
Department of Surgery 
Division of Cardio-Thoracic Surgery 
Video Assisted Thoracic Surgery and 
Thoracoscopy Privileges 
Change of Status 
Joseph J. Prorok, MD 
Department of Surgery 
Division of General Surgery 
From Active/LOA to Honorary 
Resignation 
Roberta B. Gonzalez, MD 




1bomas W. Lane, PbD 
Associate Scientific 
Psychologist 
(The Guidance Propam) 
Beverly C. Woodward, RN 
Physician Extender 
Professional - RN 
(Falnily Pecliatriciaoa - Dr. Kean) 
Change of Category 
Elizabeth D. Hawley 
Physician Extender 
Technical to Professional 
Dental Assistant to Dental Hygienist 
Jane L. Kulhamer 
Physician Extender 
Technical to Professional 




~na M. Filla, RN 
Physician Extender 
Professional - RN 
(ramar D. Baroelt, MD) 
Change Alternating Supervising 
Physician from Alan Berger, MD to 
Linda Lapos, MD 
Ruben P. Romero, PA-C 
Physician Extender 
Physician Assistant 
(F. Geoffrey TOODder, MD) 
Add Substitute Supervising Physician -
Nercy 1afari, MD 
Continued on Page 16 
Page 14 
Continued from Page 14 
Resignations 
Mary Ann Butler, RN 
Physician Extender 
Professional - RN 
(Mahmood A. Tahir, MD) 




(Children 'a HealthCare) 




(F. Geoffrey Toonder, MD) 




(Levine and Busch, PC) 
Sheri L. Fredrick-Deeb, RN 
Physician Extender 
Professional - RN 
(Cardiology Care Specialists) 




(David H. Packman, DDS) 




(Lehigh OB/GYN, PC) 
Richard R. Grabowski, PbD 
Associate Scientific 
Audiologist 
Gretchen C. Gray, RN 
Physician Extender 
Professional - RN 
(Gregory M. Lang, MD) 





Patti A. Hutehiawn, RN 
Physician Extender 
Professional - RN 
(Concepcion Tan Yen, MD) 
Mary-Lou T. Mayernick, RN 
Physician Extender 
Professional - RN 
(Iohn J. Cauel, MD) 
JUI D. Moyer, RN 
Physician Extender 
Professional - RN 
(Valley OB-GYN Associates) 
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The following actions were 
taken attha April12, 1993, 
Pharmacy and Therapeutics 
Committee Meeting 






F onnulaty Considerations 
Strrmp- tbtm Wbtlt1 
Oral Ketorolac (I'orrttiDI, SyRia-) was discussed 
fur fOrmulary addition. Key data discussed were 
its lack of advantage in clinical trials over the 10 
other NSAIDs on funnulary and its cost relative 
to other NSAID'S. Ketorolac produces similar 
pain relief to ibuprofen, naproxen and diilunisal in 
trials in post-op orthopedic and dental and oral 
surgery procedures. Table 11ists some key 
comparative data. 
Oral Oadanletron (ZDfrM, Glco) -is the oral 
funn of the previously approved injectable 
antiemetic. Oral ondansetroo is indicated fur the 
prevention of nausea and vomiting associated with 
500-lOOOmg Q4-&H *».13 
500-UXXJmg Q4-&H «XJJmg IUl5 
200-800mg Q4-8H 3200mg ll.20 
moderately emerogenic cancer chemotherapy. 
Ondansetron inhibits 5-HT1 Receptors and 
appears to block serotonin in the area posttema of 
the brain, the gut, and/or other regions of the 
central nervous system. Oral bioavailability is 
60% with peale levels seen in 1.5 hours and half 
life of 3-6 hours. Ondansetron is extensively 
metabolized via the Cyux:hrome P-450 System. 
Studies to date have compared it only to placebo 
in various chemotherapy regimens. The most 
common adverse drug reactions include head-
ache, diarrhea and coostipation. 
The recommended oral dose is 8mg given 30 
minutes befOre emetogenic chemotherapy and 
subsequent doses 4 and 8 hours after the first 
dose. It should then be given as 8mgTID fur 1-2 
days after completion of chemotherapy. 
Ondansetron has not been studied in renal 
patients. The total dose should not exceed 8mgl 
day in severe hepatic insufficiency. 
The cost of8mg ondansetron is $15 .00/tablet 
(yes, you did read it axrectl.y). The Committee 
requested that usage guidelines be developed to 
assure appropriate use. 
Naproxen Naprosyn 500mg initial, Q6.8H 1500mg 
then 
$3.36 Parmetine (P.U, SKB) - is the latest Selective 
Serotonin Reuptake Inhibitor (SSRI) to be 


















































depression. Paroxetine is more potent and more 
selective than either Buoxetine or senraline. 
Parmretine is well absorbed although availability is 
reduced due to first pass metabolism. Paroxetine 
has a half life of 12-20 hours; is highly protein 
bound (95% ), and metabolized to essentially 
inactive metabolites prior to excretion in the urine 
and feces. There appears to be wide interpatient 
phannacokinetic variability due primarily to the 
existence of exten5ive and poor metabolizers. 
This vuiabil:ity is also obsenred in renal impaired 
and cirrhotic patients and dosages should be 
adjusted. UnliJce Buoxetine, Paroxetine is 
excreted in pharmacologically significant quanti-
ties in breast mille. Therefure it should not be 
Page 17 
Formulary Considerations 
Conlillllll ........ , 
200mg 500mg 
750mg 
used in breast feeding women. 
Commoo side effects are similar to other SSRis. 
Parmetine appears 1D cause more sedation and 
amstipation than other SSRis and mere headache 
and dry mouth than fluoretine (similar to 
senraline). Parozetine causes less anorexia than 
flUOllletine. When rakm at night, Parmetine has 
caused some sleep disturbances. Consequently, 
the dose should be rakm earlier in the day. Drug 
intenctions include MAO inhibitors .(significant). 
and agents metabolized by the Cytnchrome P-
450 System (cimetidine. phenytoin. 
phenObamtal, wufirin, etc.). Patients should 
have a two week free intenal between Parmetine 
and MAOI therapies. The usual starting dose is 
Drug Use Evaluation 
If the Gilt Wtris •••••.• U.wlt! 
Famotidi.ae IV to PO - Results from a two 
month study to couva t injectable famotidine to 
oral therapy in patients currently receiving at least 
2 scheduled oral meds were discussed. Ow-t 
requests were used to SIJ8FSt conversion in 
Q12H $13.00 $2.10 
Q12H $25.00 $2.40 
Editor's Nots: The intrn1111ous route for bath t.motidine 1nd ciprotiDKICin should 
only be used when thllf'fl 1re contrlindicltions to Ofll therlpy. Effic1cy is no 
gre1ter for either mediCition when gillen IV. Also, both medicltions m1y be 
crushed 1nd 1dministered vii feeding tubes (i.e., NG, Dobhoff, etc.} if Gl 
1bsorption is felt to be 1dequ1te. · 
20mg daily. Doses may be adjusted upward in 
10mg increments no more often than weekly to 
SOmg/day. With the addition ofParoxetine and 
apparent shift away &om Trilfet:racyclics. the 
Conunittee asked Psychiatry to review these 
apnts fDr possible formulary deletions. 
Parmetine oosts $1.S0/20mg tablet. 
Dyprota (Blirlc&) - is a combination product 
cmClining nne oxide, peaolatmn and other 
protectants used to prevent/treat diaper rash. . 
Dyprotex bas similar ingredients to Desitin and is 
used similarly. Dyprou:x oomes in individual 
applicaur packages. Dyprou:x was added to the 
fOrmulary. 
appropriate patients. A total of91 (69%) out of 
131 identified patients were axwerted. 70 (53%) 
were changed from IV to PO, 20 (16%) had 
orders fDr either route and were converted to PO. 
An additional24 (18%) had therapy discontinued 
- this later group was not included in the 69% 
cmvenion. Drug acquisition savings alone 
amount to $8000 annually. H other supply and 
labor oosts were included, the savings would 
nnge to $24,000. 
CiprofloDcia IV to PO - IV Ciprofloxacin 
patients who have had no apparent 
cmtnindications to oral therapy were also 
targeted for conversion requests. While the total 
number of eligible patients (18) and number of 
successful conversion (12) were smaller, the 
savinas were also around $8,000 annually given 
the large cost difference between the PO and IV 








High empiric use (13%) continues although average length 
oftheraPV (LOT) has decreased. 
IIBcomtnendation~ Csftuidime is tlt:ommended to trelt 
gflm negative ucH/i in cefuolin tlli6t6nt pstientl or to 
trest pseudomon11 when piper~cilin is not sppropriltl 
(sllergy, resistsnceJ. 
High empiric use continues (77%) also with decreased LOT. 
Recommend6tions - IV ciproflo1t1cin use should be limited 
to ruismnt 111Dbic gram-neg1tive ucilli (e.g. 
Poudomon•s. Entllroblt:tflr, s.n.ti1}. Orll therspy should 
be considered in 111 pstients with 1 functioning Gl trlct 
Only 7 cases were reviewed. Data showed pre-op given in 
patient care areas. LOT ranging from 1 dose to 10 days 
(ave. 3.5 days) and majority with no documentation of need 
(+specimen.+ complications,+ signs of infection post-op). 
Recommendstion~ The 11'1iew liteflfllfl generally 
flt:ommends cef1zolin for mOlt surgic1l procedutl& 
Csfuolin/MIItroniiMzole or Cefotetln (2nd generation} ,,. 
11commended for prophyii1Cis in surgic11 ,,., whtfl 
Bnserobes msy be present M1ny references now 
11commend one doss 111tt:ept in prolonged oper6tions 
sndlor csrtsin proceduru. The pre-op dOSB should be 
given within 2 hours of incision. 
The Committee recommended that a more comprehensive review of surgical 
prophylaxis be conducted. 
) 
Target Antibiotics 
Data from March, 1993 were presented. Areas of 
b:us were Ceftmdine, Oprofloxac:in and 
Ampic:illin/Sulbac:tam. Ampicillin/Sulbactam 
usage review was limited to surgical prophylaxis 
cases only. 
Temporary Shortage of 
Hydralazine 
The Committee was informed that IV 
Hydnlazine is pnerally unavailable due to the 
discontinuation of production by one of the only 
two manu&cturers. Alternative agents should be 
CXXISidered if at all possible until the shortage ends 
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